WCG Introduces Breakthrough Analytics to Optimize and Accelerate Clinical Trial Outcomes

CARY, N.C., Nov. 12, 2025 /PRNewswire/ — WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of its next-generation Data & Insights Solutions. Guided by the principle that Knowing Changes Everything, WCG is redefining the clinical trial landscape by equipping sponsors and clinical research organizations (CROs) with the trial intelligence, clarity, and objectivity necessary to anticipate challenges, optimize outcomes, and accelerate breakthroughs for patients.

Powered by the depth and breadth of WCG’s renowned operational and protocol data — spanning more than 80,000 complete protocols and 40,000 operational performance-benchmarked trials — these solutions embody four foundational pillars:

  • Predictive intelligence translates raw analytics and protocol insights into actionable foresight for trial design and decision-making.
  • WCG turns complexity into clarity by transforming complicated protocol and trial data into digestible insights, with an ability to benchmark similar trials.
  • Every insight is grounded in human-centered outcomes, reducing participant and site burden.
  • As a trusted partner, WCG delivers objective, defensible intelligence relied upon by sponsors and sites worldwide.

“At WCG, our mission is to improve lives by accelerating research, together,” said Sam Srivastava, chief executive officer, WCG. “Our Data & Insights Solutions represent a transformative leap forward in trial optimization. By translating complex data into clear foresight, we enable sponsors to design trials that run smarter, faster, and smoother, helping life-changing therapies reach patients sooner.”

Drawing on decades of expertise, WCG’s robust analytics and AI-powered methodologies illuminate critical patterns across thousands of trials, enabling industry partners to design protocols, anticipate enrollment challenges, select ideal countries and sites, and proactively identify operational risks before they arise. These capabilities empower clients to move beyond fragmented insights and instead harness evidence-based intelligence, driving trial success from the very start.

“Our industry-leading analytics expertise allows us to deliver objective and trustworthy insights, giving clients the information they need to identify risks early and drive better decisions to achieve greater impact for patients. When we know better, we do better. Knowing changes everything,” said Mette Andersen, general manager, Data, Analytics, and Insights Solutions, WCG.

To learn more about how WCG’s Data & Insights Solutions are transforming clinical research, visit https://www.wcgclinical.com/knowing/.

About WCG

WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit wcgclinical.com or follow us on LinkedIn

View original content to download multimedia:https://www.prnewswire.com/news-releases/wcg-introduces-breakthrough-analytics-to-optimize-and-accelerate-clinical-trial-outcomes-302612420.html

SOURCE WCG

Staff

Recent Posts

GaraHerb Supplement Facts, Ingredient Label Details, and Product Disclosures: A 2026 Informational Overview of Male Enhancement Supplement Options

Label-verified GaraHerb ingredient disclosures, manufacturing and policy transparency details, and what consumers searching for GaraHerb…

10 hours ago

Cannabix Technologies announces Non-Brokered LIFE Private Placement

  NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…

10 hours ago

LuminEye Nano-Drops Product Information Updated as Consumer Interest in Eye Health Supplement Options and Vision Support Alternatives Grows in 2026

An informational overview examining category context, publicly available product disclosures, and what consumers often consider…

10 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”)…

10 hours ago

Laughland Teeth Whitening Kit: Ingredients, Disclosures, and What Consumers Are Researching in 2026

A 2026 informational overview of the Laughland whitening kit covering publicly available ingredient disclosures, product…

10 hours ago

The UA Sprinkler Fitters Local 669 JATC – Notice of Privacy Incident

Landover, Maryland, February 6, 2026- The UA Sprinkler Fitters Local 669 Joint Apprenticeship and Training…

19 hours ago